The epidermis as a bioreactor: Topically regulated cutaneous delivery into the circulation

Human Gene Therapy

Volumn 13, Issue 9, 2002, Pages 1075-1080

  Cao, Tongyu ^a   Tsai, Sophia Y ^a   O'Malley, Bert W ^a   Wang, Xiao Jing ^a   Roop, Dennis R ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; MIFEPRISTONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOREACTOR; CONTROLLED STUDY; EPIDERMIS; FEMALE; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE SWITCHING; GENE TARGETING; GROWTH HORMONE BLOOD LEVEL; KERATINOCYTE; MOUSE; NONHUMAN; SKIN GRAFT; TRANSGENE; TRANSGENIC MOUSE; WEIGHT GAIN;

ANIMALS; BIOREACTORS; BODY WEIGHT; EPIDERMIS; FEASIBILITY STUDIES; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; HUMAN GROWTH HORMONE; HUMANS; KERATINOCYTES; MICE; MICE, NUDE; MICE, TRANSGENIC; MIFEPRISTONE; PROMOTER REGIONS (GENETICS); RECEPTORS, PROGESTERONE;

ANIMALIA; MUS MUSCULUS;

EID: 0036295629     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303402753812476     Document Type: Article

References (21)

1. Circulating human factor IX produced in keratin-promoter transgenic mice: A feasibility study for gene therapy of haemophilia B
2. Sustainable systemic delivery via a single injection of lentivirus into human skin tissue
3. Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor
4. Adenovirus-mediated regulable target gene expression in vivo
5. Regulated cutaneous gene delivery: The skin as a bioreactor
6. Correction of the coagulation defect in hemophilia A mice through factor VIII expression in skin
7. Systemic delivery of secreted protein by grafts of epidermal keratinocytes: Prospects for keratinocyte gene therapy
8. Towards gene therapy for haemophilia B using primary human keratinocytes
9. Gene therapy for genetic skin disease
10. Overexpression of an Agouti cDNA in the skin of transgenic mice recapitulates dominant coat color phenotypes of spontaneous mutants
11. A cutaneous gene therapy approach to human leptin deficiencies: Correction of the murine ob/ob phenotype using leptin-targeted keratinocyte grafts
12. Keratinocyte gene therapy for systemic diseases: Circulating interleukin 10 released from gene-transferred keratinocytes inhibits contact hypersensitivity at distant areas of the skin
13. Expression of an exogenous growth hormone gene by transplantable human epidermal cells
14. HGH 100T
15. Metallothionein-human GH fusion genes stimulate growth of mice
16. Systemic replacement therapy from genetically modified epidermal keratinocytes
17. The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor
18. Transgenic studies with a keratin promoter-driven growth hormone transgene: Prospects for gene therapy
19. Development of gene-switch transgenic mice that inducibly express transforming growth factor β1 in the epidermis
20. A regulatory system for use in gene transfer
21. Ligand-inducible and liver-specific target gene expression in transgenic mice